5-140114310-TGGCGGCGGC-TGGCGGCGGCGGCGGC
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_005859.5(PURA):c.141_146dupCGGCGG(p.Gly48_Gly49dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000612 in 1,291,080 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_005859.5 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PURA | ENST00000331327.5 | c.141_146dupCGGCGG | p.Gly48_Gly49dup | disruptive_inframe_insertion | Exon 1 of 1 | 6 | NM_005859.5 | ENSP00000332706.3 | ||
PURA | ENST00000651386.1 | c.141_146dupCGGCGG | p.Gly48_Gly49dup | disruptive_inframe_insertion | Exon 2 of 2 | ENSP00000499133.1 | ||||
PURA | ENST00000505703.2 | c.141_146dupCGGCGG | p.Gly48_Gly49dup | disruptive_inframe_insertion | Exon 2 of 2 | 3 | ENSP00000498560.1 | |||
PURA | ENST00000502351.1 | c.*50_*51insGGCGGC | downstream_gene_variant | 2 | ENSP00000498760.1 |
Frequencies
GnomAD3 genomes AF: 0.0000860 AC: 12AN: 139490Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000685 AC: 2AN: 29190Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 18126
GnomAD4 exome AF: 0.0000582 AC: 67AN: 1151502Hom.: 0 Cov.: 31 AF XY: 0.0000591 AC XY: 33AN XY: 558774
GnomAD4 genome AF: 0.0000860 AC: 12AN: 139578Hom.: 0 Cov.: 32 AF XY: 0.0000884 AC XY: 6AN XY: 67850
ClinVar
Submissions by phenotype
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
PURA-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at